Medicare has different routes
Medicare helps pay for prescription medicines through its Part D benefit.
As of September 26, 2026, usual Part D coverage still excluded medicines when used for weight loss.
Why this source matters
Part D is Medicare’s prescription-drug benefit. This is the usual benefit, separate from the temporary programme below.
On that date, a medicine used for another accepted medical reason could qualify for Part D payment.
Examples include treating type 2 diabetes (high blood sugar) or reducing the chance of serious heart problems in certain patients.
The plan still checks the reason for treatment, its list of medicines it covers and any permission needed before the pharmacy supplies the medicine.
Why this source matters
A possible route to coverage does not mean a particular plan has approved a particular claim.
The temporary weight-loss programme
In the September 26, 2026 check, Medicare had a temporary weight-loss medicine programme called the GLP-1 Bridge.
In this name, GLP-1 refers to the group of medicines the programme covers; it does not mean all weight-loss medicines.
Part D members who met the programme’s rules paid $50 each month for selected weight-loss tablets or shots.
The programme began July 1, 2026 and ended December 31, 2027.
The $50 payment was separate from usual Part D medicine costs.
It did not count towards Part D’s yearly cap on your spending for covered medicines.
Even after reaching that yearly limit, the Bridge’s $50 monthly payment still applied.
The Bridge offered no extra help with the bill for people on low incomes.
Why this source matters
The programme covers certain weight-loss medicines. The eligibility details matter for each person.
Who may qualify for the Bridge?
Under the Bridge rules checked September 26, 2026, the minimum age was 18 years.
There were weight and health tests, based on when treatment began.
The weight test used body mass index (BMI), which compares a person’s weight and height.
Ask the prescriber to calculate this number and check which route applies.
Why this source matters
Age alone did not qualify someone. The prescriber needed to check the weight and health rules.
One route required a BMI of 35 or more.
A second required a BMI of 30 or more plus a specified heart-failure diagnosis, hard-to-control high blood pressure or a specified kidney-disease stage.
These diagnoses have exact medical limits; ask the prescriber to check whether your health record meets them.
For the third route, a BMI of at least 27 was needed along with one of these: pre-diabetes, a heart attack or stroke in the past, or limb artery disease causing symptoms.
With pre-diabetes, blood sugar is above the usual range but below the diabetes range.
Why this source matters
These are starting points for checking the rules, not the full medical tests. A weight number alone is not enough for the second or third route.
When a different payment route applies
People with type 2 diabetes were directed to usual Part D coverage, not the Bridge.
Part D payment still depended on the plan’s decision; it was not automatic.
Certain sleep-breathing and liver conditions, or a prescription to reduce serious heart problems, also led to usual Part D instead.
Ask the plan what you would pay under that route.
Why this source matters
The exclusions name specific diagnoses. Do not assume that any sleep or liver problem rules you out.
The type of Medicare plan also mattered; ask whether your plan was one of the types included.
The Bridge was unavailable in 2026 to anyone whose Part D plan had already paid for one of these medicines during 2026.
A prescription and the programme’s permission before treatment were required.
The medicine had to be prescribed along with ongoing planned food and physical-activity changes.
Why this source matters
Have the prescriber and plan review all the rules for your case, including plan type, earlier payments and permission before treatment.